Document is current
Any future updates will be listed below
-
Authors
Brainerd, Cara https://orcid.org/0009-0006-1100-4885
Singh, Maya A. https://orcid.org/0000-0002-2025-5356
Tatka, John
Craig, Cosette https://orcid.org/0000-0001-5917-3561
Gilligan-Steinberg, Shane https://orcid.org/0000-0001-9036-565X
Panpradist, Nuttada https://orcid.org/0000-0002-2733-4110
Chang, Megan M. https://orcid.org/0000-0003-3272-8226
Lutz, Barry https://orcid.org/0000-0003-4298-4901
Olanrewaju, Ayokunle O. https://orcid.org/0000-0003-4776-1774
-
Funding
Funding for this research was provided by:
Washington Research Foundation
- License Information
-
More Information
Article History
Received: 13 August 2024
Revised: 30 September 2024
Accepted: 7 October 2024
First Online: 28 October 2024
Declarations
:
: A.O. is an inventor on a patient filed (PCT/US2020/037609) based on related work on enzymatic assays for measuring reverse transcriptase inhibitors. Provisional patent applications have been filed on several components of the Harmony reader. N.P. and B.L. are inventors on two patent applications: PCT/US2021/041035 (pending international patent application) and 63/165,029 (pending U.S. provisional patent). N.P. and B.L. hold equity in a startup company that has licensed related technology and supports ongoing work in the B.L. laboratory at the University of Washington. B.L. serves as a scientific advisor for the company. The company played no role in the funding, study design, data analyses, or reporting of results for this study. C.B., M.A.S., J.T., C.C., S.G., and M.M.C. have no conflicts of interest to declare.
